Sab Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.85

+0.02 (+0.52%)

As of Mar 29, 10:35 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +715.8% upside

Low Target $26.29

Average Target $31.41

High Target $48.84

Current Price $3.85

Current
$3.85

Target
$31.41

$26.29 $31.41 avg $48.84

Scenario Analysis

Bear Case

$26.29

582.9%

Low target

Base Case

$31.41

+715.8%

Avg target

Bull Case

$48.84

+1,168.6%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$6.60

-41.7% from high

52-Week Low

$1.00

+285.0% from low

Target vs 52W High

$31.41

+375.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%